7th Mar 2008 07:01
Sinclair Pharma PLC07 March 2008 Sinclair Pharma plc (the "Company") The Company was informed on 6 March 2008 that Dr. Michael Flynn, Chief ExecutiveOfficer, acquired 50,000 ordinary shares of 1p each in the Company ("OrdinaryShares") at 47.62 pence per share on 4 March 2008. The Ordinary Shares purchased through this transaction are held in Dr. Flynn'sSIP. Following this acquisition of Ordinary Shares Dr. Flynn has an interest ina total of 9,482,288 Ordinary Shares equalling approximately 10.2 per cent. ofthe issued share capital in the Company. For further information please contact: Sinclair Pharma plc Tel: +44 (0) 1483 410 600Jerry Randall, CFO This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma